Amedisys, Inc. (NASDAQ:AMED) Short Interest Update

Amedisys, Inc. (NASDAQ:AMED) was the target of a significant decline in short interest in December. As of December 15th, there was short interest totalling 2,210,000 shares, a decline of 14.7% from the November 30th total of 2,590,000 shares. Based on an average trading volume of 539,400 shares, the short-interest ratio is presently 4.1 days. Currently, 6.9% of the company’s stock are short sold.

Amedisys Trading Up 0.6 %

NASDAQ AMED opened at $90.49 on Tuesday. The stock has a market capitalization of $2.96 billion, a PE ratio of 35.91, a price-to-earnings-growth ratio of 1.84 and a beta of 0.73. The firm has a 50 day moving average of $90.45 and a two-hundred day moving average of $94.47. Amedisys has a 52 week low of $82.15 and a 52 week high of $98.95. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.05.

Amedisys (NASDAQ:AMED) last issued its quarterly earnings data on Wednesday, November 6th. The health services provider reported $1.00 earnings per share for the quarter, missing the consensus estimate of $1.19 by ($0.19). Amedisys had a return on equity of 12.20% and a net margin of 3.57%. The company had revenue of $587.67 million for the quarter, compared to analysts’ expectations of $586.75 million. During the same quarter in the prior year, the firm posted $0.98 EPS. The firm’s quarterly revenue was up 5.7% compared to the same quarter last year. As a group, research analysts expect that Amedisys will post 4.45 EPS for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors have recently bought and sold shares of the business. National Bank of Canada FI boosted its holdings in shares of Amedisys by 119.0% in the third quarter. National Bank of Canada FI now owns 55,592 shares of the health services provider’s stock valued at $5,365,000 after acquiring an additional 30,213 shares in the last quarter. Dimensional Fund Advisors LP increased its holdings in shares of Amedisys by 4.0% in the 2nd quarter. Dimensional Fund Advisors LP now owns 514,166 shares of the health services provider’s stock valued at $47,202,000 after purchasing an additional 19,660 shares in the last quarter. Geode Capital Management LLC increased its stake in Amedisys by 1.3% in the 3rd quarter. Geode Capital Management LLC now owns 567,105 shares of the health services provider’s stock valued at $54,746,000 after purchasing an additional 7,071 shares in the last quarter. Quarry LP acquired a new stake in Amedisys in the third quarter valued at $2,569,000. Finally, Charles Schwab Investment Management Inc. boosted its position in shares of Amedisys by 2.7% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 346,082 shares of the health services provider’s stock worth $33,400,000 after buying an additional 9,004 shares in the last quarter. 94.36% of the stock is currently owned by institutional investors and hedge funds.

About Amedisys

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.